Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 454

Similar articles for PubMed (Select 16601502)

1.

Attention deficit/hyperactivity disorder: complexities and controversies.

Schonwald A, Lechner E.

Curr Opin Pediatr. 2006 Apr;18(2):189-95. Review.

PMID:
16601502
2.

Update: attention deficit/hyperactivity disorder in the primary care office.

Schonwald A.

Curr Opin Pediatr. 2005 Apr;17(2):265-74. Review.

PMID:
15800424
3.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
4.
5.

Treatment of attention deficit hyperactivity disorder in adults.

Greenfield B, Hechman L.

Expert Rev Neurother. 2005 Jan;5(1):107-21. Review.

PMID:
15853481
6.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
7.

Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.

Kaplan G, Newcorn JH.

Pediatr Clin North Am. 2011 Feb;58(1):99-120, xi. doi: 10.1016/j.pcl.2010.10.009. Review.

PMID:
21281851
8.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
9.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
10.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

11.

Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.

Rader R, McCauley L, Callen EC.

Am Fam Physician. 2009 Apr 15;79(8):657-65. Review.

12.

Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.

Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ.

Pediatrics. 2008 Jan;121(1):e65-72. doi: 10.1542/peds.2007-0383.

13.
14.

Attention deficit/hyperactivity disorder: a review and update.

Cormier E.

J Pediatr Nurs. 2008 Oct;23(5):345-57. doi: 10.1016/j.pedn.2008.01.003. Epub 2008 Jun 20. Review.

PMID:
18804015
15.
16.

Multimodal treatment for childhood attention-deficit/hyperactivity disorder.

Kaiser NM, Hoza B, Hurt EA.

Expert Rev Neurother. 2008 Oct;8(10):1573-83. doi: 10.1586/14737175.8.10.1573. Review.

PMID:
18928349
17.

Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.

Rostain AL.

Postgrad Med. 2008 Sep;120(3):27-38. doi: 10.3810/pgm.2008.09.1905. Review.

PMID:
18824823
18.

Adderall XR: long acting stimulant for single daily dosing.

Sallee FR, Smirnoff AV.

Expert Rev Neurother. 2004 Nov;4(6):927-34. Review.

PMID:
15853519
19.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk